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Summary
It has been recognized that the development of new therapeutic drugs is a complex and
expensive process. A large number of factors affect the activity in vivo of putative candidate
molecules and the propensity for causing adverse and toxic effects is recognized as one of
the major hurdles behind the current ”target-rich, lead-poor” scenario.
Structure-Activity Relationship (SAR) studies, using relational Machine Learning (ML)
algorithms, have already been shown to be very useful in the complex process of rational
drug design. Despite the ML successes, human expertise is still of the utmost importance
in the drug development process. An iterative process and tight integration between the
models developed by ML algorithms and the know-how of medicinal chemistry experts
would be a very useful symbiotic approach. In this paper we describe a software tool that
achieves that goal – iLogCHEM. The tool allows the use of Relational Learners in the task
of identifying molecules or molecular fragments with potential to produce toxic effects,
and thus help in stream-lining drug design in silico. It also allows the expert to guide the
search for useful molecules without the need to know the details of the algorithms used.
The models produced by the algorithms may be visualized using a graphical interface, that
is of common use amongst researchers in structural biology and medicinal chemistry. The
graphical interface enables the expert to provide feedback to the learning system. The
developed tool has also facilities to handle the similarity bias typical of large chemical
databases. For that purpose the user can filter out similar compounds when assembling a
data set. Additionally, we propose ways of providing background knowledge for Relational
Learners using the results of Graph Mining algorithms.
*To whom correspondence should be addressed. Email: rcamacho@fe.up.pt
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1 Introduction
The amount of information concerning chemical compounds available in databases has been
increasing at a considerable pace in the last years, changing the whole process of discovery and
development of new drugs. Drug databases have been used as a starting point for screening
candidate molecules, enabling the pharmaceutical industry to produce over 100,000 new com-
pounds per year [1]. Promising compounds are further analyzed in the development process,
where, among other studies, their potential toxicity is assessed. This is a complex and costly
process that often requires years before the compounds can be tested in human subjects [2].
Additionally, about 90% of the initial drug candidates fail to reach the market due to their tox-
icological properties [3]. This fact highlights the importance of determining potentially toxic
features as early as possible in the development process.
Toxicity tests determine whether or not a candidate molecule is likely to produce toxic ef-
fects in humans, and usually involve the use of animal models at a pre-clinical stage. As the
number of biological targets increases, and hence the demand for drug screening campaigns,
there is a growing need for efficient in silico methods to predict the toxicity of chemical com-
pounds. This problem of estimating the toxicity of drugs has been addressed through three
major approaches: i) regression from physico-chemical properties; ii) hand-built expert sys-
tems and; iii) machine learning [4, 5]. Toxicity prediction programs commercially available in-
clude TOPKAT (toxicity-prediction by computer-assisted technology), DEREK [6] (deductive
estimation of risk from existing knowledge), CSGenoTox, MetaDrug and HazardExpert [7].
These programs have a common characteristic: they are classified as ”global” models [8] since
they were developed using a non-congeneric set of chemicals. In fact, it is not mandatory that
the chemicals in these data sets are congeneric, but they should share structural features. Be-
sides these commercially available programs, other studies have been published using machine
learning [9, 10, 4, 11, 5].
There is a large body of work on using Machine Learning and more precisely multi-relational
learning in the form of Inductive Logic Programming (ILP) to discover models of drug activity.
These studies assume that the set of compounds is divided into two subsets: active and inactive.
The task is to obtain rules that differentiate the active versus the inactive compounds. The
following information is most often available for these compounds:
• two-dimensional (2D) structural information (i.e., atoms and bonds in the compound);
• physico-chemical properties such as molecular weight, lipophilicity and several other
chemical properties of interest.
ILP learners can cope well with the complex nature of chemical compounds. Moreover, they
guarantee interpretability: the models are concise and can be presented in a way that are easily
understandable by chemists.
In this study we investigate the impact of compound similarity (herein referred as drug homol-
ogy) in the construction of predictive models to assess the toxicity of small molecules. More
precisely, we aim at addressing the following hypothesis:
H0: Drug homology within the data sets has a significant impact on the performance of learn-
ing systems.
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Our study is motivated by the observation that most previous works assume that entries in a
database are independent and identically distributed (i.i.d.). In practice, most compounds are
not obtained independently. Often, one compound in the data base is obtained by incremental
chemical modification of a similar compound, known to the chemist. Arguably, this raises
the question of whether reported results are reliable and will hold up for novel drugs. On the
other hand, it is critical to notice that two similar compounds may in fact have quite different
chemical properties. This suggests that it may be worthwhile to consider different compounds
even if they are mostly similar.
In order to prove/disprove H0, first we must be able to measure drug similarity. To this end
we apply a measure commonly used in the Computational Chemistry community, the Tanimoto
index/coefficient between two molecules. As a second step, we identify separate clusters of
similar molecules and find representatives, a process that we call filtering. Finally, we perform
the learning of the models using relational learners to construct comprehensible models, that
may be valuable to bring insights into the workings of toxicity We have used the combination of
two Relational Learners techniques: Graph Mining (GM); and Inductive Logic Programming
(ILP).
The learning with ILP was made using a software tool, iLogCHEM 1, that is described hereby
and allows the expert to guide the search for useful molecules without the need to know the
detail of the algorithms used. The models produced by the algorithms may be visualized by
the experts and an easy graphical interface enables the expert to provide feedback to the learn-
ing system. The evaluation was performed on three data sets available from the Distributed
Structure-Searchable Toxicity (DSSTox) Public DataBase Network [12].
2 A tool for interactive drug design
We based our work in iLogCHEM, an interactive tool for chemo-informatics. This system is
designed to allow search and manipulation of drug patterns. The input is given as a standard
formatted description of the molecules. The output is provided visually, or as text files in
standard chemical file formats.
iLogCHEM is very well suited to our problem because it provides a natural vehicle for com-
bining structural and property information within a single framework. This is possible because
iLogCHEM represents molecules as a set of Prolog facts. In the original implementation [13],
Prolog facts describe atoms in the molecule, or bonds between atoms. In more recent imple-
mentations, facts may also describe global properties of a compound, or may even describe
properties of a number of atoms in the molecule. The iLogCHEM representation is therefore
very powerful, and fits our stated goal of combining propositional and relational information.
Notice, on the other hand, that it is less compact than the SMILES [14] based representation
applied in other tools, such as MOLFEA [15] and SMIREP [16].
At its core, iLogCHEM relies on Inductive Logic Programming (ILP) to find the most inter-
esting patterns. More precisely, iLogCHEM ’s input will include a set of active and inactive
molecules. In its standard mode of use, the system tries to generate the set of smallest patterns
that are characteristic of active molecules. Patterns are generated incrementally. iLogCHEM
1Available at http://code.google.com/p/logchem/
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starts from the empty pattern and grows this pattern by adding either bonds or molecular prop-
erties until the best pattern is found.
Interaction with the system proceeds through a graphical user interface. The system currently
asks users for files in SDF format, that naturally includes atom and bond data on a set of
molecules, but also allows inclusion of drug attributes. This file may label the compounds as
active or inactive, or a second file may provide the labels. SDF is a very popular format, and
particularly useful to us as it is a vehicle for propositional information known to be relevant to
drug activity, and it can also convey 3D structure to be visualized by the system’s visualizer.
Formats such as SML can be easily translated into SDF through tools such as OpenBabel [17].
The advantages of SDF make it a natural data set distribution format for a variety of purposes.
One example is the DSSTox collection of toxicity data sets with approximately 2000 molecules,
including 2D and 3D information. A second example is the DTP AIDS data base [18], also
available from the NIH.
Given a SDF file, the first step is to pre-compute an user-defined set of attributes. One can select
from a predefined set of 22 1D descriptors, 300 molecular fingerprints, and 242 2D descriptors.
The selected descriptors can be analyzed either with propositional tools, or may be integrated
into the ILP search.
iLogCHEM is an interactive system. It is up to the user to choose a search strategy and to exploit
the different options offered by the system. At the core we have the pattern discovery algorithm.
This algorithm is invoked after molecules are input and parameters of interest pre-computed.
It relies on the standard ILP system Aleph [19], significantly rewritten to optimize this specific
problem. Namely, we maintain fragments in a standard form, based on Morgan’s algorithm,
and we use tabling [20] to store fragments so that repeated fragments are never revisited in the
search.
To be more precise, the iLogCHEM algorithm is an extension of the greedy cover algorithm
with ILP’s Mode Directed Inverse Entailment algorithm (MDIE) [21]. The first implementa-
tion of this algorithm was the Progol system. Later, it has been implemented in several other
ILP systems, such as April [22], and Aleph [19]. We chose MDIE because it is a seed-based
algorithm, that is, it directs the search from a seed molecule, usually an active molecule. In
other words, in MDIE, at each step we choose a seed, and then we search only for patterns
that are guaranteed to match this seed molecule. This ensures that every rule will cover at least
one example. Moreover, by careful selecting the seeds we can improve the algorithm’s perfor-
mance [23]. Greedy cover removal is a standard Artificial Intelligence algorithm, based on the
idea of removing the examples covered in a search step for the next search step. Greedy cover
removal thus directs the search to examples that have not been explained by previous patterns.
The output of this process is a set of patterns (technically, in ILP they are called a theory). From
the user’s point of view, what is relevant is the patterns, and iLogCHEM supports the idea that
individual patterns and how they cover molecules should be easy to understand and manipulate.
In practice, this is implemented by computing the coverage of patterns, i.e., the molecules that
match a certain pattern, and by allowing the user to visualize how each pattern instantiates to
each covered molecule. Molecule visualization is a challenging field in itself. The system relies
on VMD [24] to display the molecules and the matching substructures.
Figure 1 shows an actual example of iLogCHEM displaying a pattern, in this case a pattern
discovered for the DTP AIDS data set. The molecule is displayed using the standard sticks
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Figure 1: Pattern (wider atoms and bonds) discovered in the DTP AIDS data set using ILP.
Figure 2: An Example Pattern from a Small Organic Molecule: A-alpha-C.
representation for chemical bonds. The pattern is emphasized by displaying atoms and bonds
as wider balls and sticks. In this case, standard coloring shows that the pattern includes a
sulphur atom (in yellow) in the vicinity of part of an aromatic ring.
2.1 Pattern Matching
As we have discussed so far, a key problem in the system is how to compute the number of
molecules to support the pattern. ILP systems rely on logical refutation for this purpose.
A first problem is clear if we consider the following Prolog representation of the N = C = N
pattern:
active(C)←
atom(C, Id1, c)∧
atom bond(C, Id1, Id2, c, n, 2)∧
atom bond(C, Id1, Id3, c, n, 2)
The pattern has a head that labels it and receives the molecule ID in a match as variable C. It
is formed out of atom/3 and atom bond/6 properties, or goals. The clause can be seen as
describing the pattern as rooted in an arbitrary node. The atom property marks an atom Id1 as
root of the tree. The atom bond property describes an edge in the tree, by giving the current
molecule C, the parent node reference Id1, the child’s reference Id2 and Id3, the parent’s atom
(strictly unnecessary)2, the child’s atom, and last, the type of bond.
2The type of atom Id1, a carbon (c), is determined already by the first literal of the clause.
C
op
yr
ig
ht
 2
01
1 
Th
e 
A
ut
ho
r(
s)
. P
ub
lis
he
d 
by
 J
ou
rn
al
 o
f I
nt
eg
ra
tiv
e 
B
io
in
fo
rm
at
ic
s.
 
Th
is
 a
rti
cl
e 
is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
C
om
m
on
s 
A
ttr
ib
ut
io
n-
N
on
C
om
m
er
ci
al
-N
oD
er
iv
s 
3.
0 
U
np
or
te
d 
Li
ce
ns
e 
(h
ttp
://
cr
ea
tiv
ec
om
m
on
s.
or
g/
lic
en
se
s/
by
-n
c-
nd
/3
.0
/).
Journal of Integrative Bioinformatics, 8(3):182, 2011 http://journal.imbio.de
doi:10.2390/biecoll-jib-2011-182 5
Imagine we match a molecule A − α − C (Figure 2) against this pattern. Clearly, there is
no match. Unfortunately, logical inference will match the same nitrogen against Id2 and Id3.
Logically, it is valid to match two variables against the same atom, and the system would
erroneously report a match. This problem is known as Object Identity [25], and the system
addresses it by constraining the logical rules so that different variables must match different
atoms:
active(C)←
atom(C, Id1, c)∧
atom bond(C, Id1, Id2, c, n, 1)∧
Id1 6= Id2∧
atom bond(C, Id1, Id3, c, n, 1)∧
Id1 6= Id3 ∧ Id2 6= Id3
2.2 Integrating Structural Information in the search
The iLogCHEM system has the ability to integrate complementary information into the pattern
search process. To do so, it is sufficient to declare that one wants different types of goals, or
properties, in the logical rule.
Properties of interest are obtained through the graphical interface, and then passed on to the
miner. In iLogCHEM the user may choose from a wide set of 1D molecular descriptors.
As an example, consider the following extended pattern for the CPDBAS data set [12]:
active(C)←
logp(C,L) ∧B ≤ −0.73333657∧
atom(C, Id1, c)∧
atom bond(C, Id1, Id2, c, c, 4)∧
atom bond(C, Id2, Id3, c, o, 4)
The constant −0.73333657 is obtained from the seed example. More precisely, MDIE enumer-
ates all facts in the data base that are connected to the seed example (in this case, it enumerates
all facts for the seed molecule). Numerical constants occurring in these facts, such as the con-
stant −0.73333657, are stored and then reused for pattern generation.
2.3 Interactive Search and Refinement
After choosing the data set of molecules and then filtering them out using the Tanimoto distance,
the user may launch the ILP component, obtaining a set of patterns. The user will then often
choose to visualize interesting rules in the model.
Two possible interactions are possible. First, the user may decide to do a “local and manual”
search. Alternatively, she or he can specify constraints on the visualized pattern and ask the
ILP system to produce a new model.
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In the first case the user may incrementally produce changes in the pattern (adding or deleting
atoms and/or bonds) and then ask iLogCHEM to immediately evaluate the modified pattern.
Whenever an evaluation is done the user will see a list of the “positive and negative” molecules
covered.
If “local and manual” search does not produce the desired results the user may interactively
(again adding/removing atoms and bonds) define a new pattern. This new pattern can be con-
verted into a clause and used as the starting clause of the search space. That is, the user com-
mands the system to find useful extensions of the provided pattern.
3 Graph Mining as feature construction for ILP
Another flavor of Relational Learning is Graph Mining (GM). Similarly to ILP, GM can also
be very helpful in the Drug Design process and particularly in the toxicity problem we are ad-
dressing with our tool. There are several tasks that GM can solve (see [26] for a detailed survey
on GM systems) but we are particularly interested in the discovery of frequent sub-graphs. As
the structures of molecules can be adequately represented by a graph, a GM algorithm can be
used to identify sub-graphs that occur frequently in certain groups of molecules (toxic ones, for
example) and do not occur in some other group (non-toxic ones). We have used this feature
of frequent sub-graph discovery to identify fragments of toxic molecules that may be useful to
explain toxicity.
Although the ILP algorithms can perform this task of discovering fragments in molecules, they
are generally less efficient than the GM algorithms. However ILP can accept, in an easy way,
additional and non-structural information that could be useful for explaining toxicity. With
these premises in mind, we have combined the two Relational Learning approaches taking
advantage of the best features of each one. We have used the efficiency of GM algorithms
(Moss system ([27])) for pre-processing of the data to discover frequent fragments that are then
provided to the ILP system as background knowledge. This background knowledge is then
“complemented” with information such as molecular descriptors and a library of well known
functional groups.
4 Similarity bias in drug design collections
The chemical space of small organic molecules is quite unevenly populated [28], with highly
populated clusters around the so-called lead compounds and void spaces often encompassing
unexplored molecular structures.
In this work we assess the bias introduced by structural similarity amongst compound collec-
tions used in drug design studies. To do so, we rely on the Tanimoto Coefficient to compute the
similarity between two molecules based on a set of molecular descriptors.
Given molecules A and B described by a vector of coefficients, the Tanimoto coefficient, also
known as the extended Jacquard coefficient, is obtained as:
T (A,B) =
‖A ·B‖
‖A‖2 + ‖B‖2 − ‖A ·B‖
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A Tanimoto coefficient value of 1.0 indicates total similarity between the two molecules, whereas
a value of zero indicates total dissimilarity. Notice that the Tanimoto coefficient highly depends
on the attributes used to describe a compound. In this study, we use both 1D and 2D descriptors,
as discussed in Section 5.2.
filter(SMD,Th):
Given: a set of molecule descriptions (SMD), a threshold for the Tanimoto Coefficient (Th).
Return: a set of molecule descriptions representing a set of molecules for which there is
no pair of molecules that have a similarity above Th.
1. foreach m1 ∈ SMD do
2. foreach m2 ∈ SMD AND m2 < m1 do
3. sim[m1][m2] = TC(m1,m2)
4. endforeach
5. endforeach
6. C = cluster(sim, Th)
7. return medoids(C)
Figure 3: Filtering procedure using the Tanimoto coefficient. sim is a lower triangular similarity
matrix. TC() is a function that computes the Tanimoto coefficient between two molecules. cluster()
is a procedure that clusters molecules that are “more similar” than the Th value. medoids() returns
for each cluster the medoid molecule.
4.1 Reducing the Similarity bias
In order to reduce the similarity bias we have constructed a filter that implements the procedure
described in Figure 3. A similarity matrix (lines 1 to 5 of the procedure) is initially computed.
Using the similarity matrix, we identify (line 6) clusters of molecules with similarity above a
specified threshold. Finally (line 7), for each cluster the procedure returns the cluster’s medoid
as the representative molecule.
The filtering procedure discards sets of similar molecules and retains the “most representative”
molecule of each set of similar molecules. As an example, using the similarity matrix con-
structed with the molecules of the Carcinogenic Potency Database (CPDBAS), we have built
the dendogram of Figure 4. There are cases where toxic molecules (represented by ’++’ in the
dendogram) and non-toxic ones (represented by ’–’) are placed in the same cluster indicating
that they are structurally similar. This finding confirms that positive and negative examples may
correspond to very similar molecules and indeed may be difficult to discriminate (which makes
the learning process hard). Thus the use of the filtering procedure described above does not
ensure separation of similar positive and negative examples, if only one of the groups is kept.
To overcome this potential problem we have implemented a different filtering procedure where
we apply the clustering to the toxic and non-toxic molecules separately.
Figure 4: Part of the dendogram (using MEGA software [29]) for CPDBAS molecules. In the
picture ’++’ indicates a drug with positive toxicity tests, ’–’ a drug with negative toxicity tests and
’+-’ a drug with some positive and some negative toxicity tests.
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5 Tool Testing
5.1 Data Sets
We have used three data sets available from the Distributed Structure-Searchable Toxicity
(DSSTox) Public DataBase Network from the U.S. Environmental Protection Agency3. The
DSSTox database project is targeted to toxicology studies and uses a standard chemical struc-
ture annotation. The data sets used are briefly described below and characterized in terms of
number of molecules in Table 1.
Table 1: Data set characterization in terms of the number of toxic and non-toxic molecules, with
and without filtering. N1/N2 in each cell represents N1 toxic molecules and N2 non-toxic molecules.
T.c. stands for the Tanimoto coefficient
data set without mixed filtering separated filtering
filtering T.c.= 0.8 T.c.= 0.6 T.c.= 0.8 T.c.= 0.6
(%) (%) (%) (%)
CPDBAS 843/966 51.7/79.9 35.7/55.1 56.2/60.6 43.3/48.3
DBPCAN 80/98 71.3/43.9 60.0/31.6 71.3/45.9 62.5/33.7
NCTRER 131/93 44.3/67.7 25.2/45.2 48.1/74.2 25.2/54.8
CPDBAS: The Carcinogenic Potency DataBase (CPDB) contains detailed results and analyzes
of 6540 chronic, long term carcinogenesis bio assays.
NCTRER: Researchers within FDA’s National Center for Toxicological Research (NCTR)
generated a database of experimental estrogen receptor (ER) binding results with the purpose
of developing improved QSAR models to predict ER binding affinities. The NCTRER database
provides activity classifications for a total of 224 chemical compounds, with a diverse set of
natural, synthetic and environmental estrogens.
DBPCAN: The water disinfection by-products database contains predicted estimates of car-
cinogenic potential for 178 chemicals.The goal is to provide informed estimates of carcino-
genic potential to be used as one factor in ranking and prioritizing future monitoring, testing,
and research needs in the drinking water area.
5.2 Background knowledge
In addition to the original database information tags/entries, 50 molecular descriptors were
calculated with Chemaxon’s GenerateMD program4. These molecular descriptors belong to a
set of pre-defined categories [30]. In our data sets we used the constitutional-based descriptors,
also known as 1D descriptors, and the topological-based descriptors, also called 2D descriptors.
Furthermore, we generated molecular fingerprints using the Open Babel program [31]. These
fingerprints were then converted into binary attributes that represent the presence or absence of
a particular chemical substructure in the compound, such as fused rings, alkene, lactone, and
enolether, in a total of 300 substructures.
3http://www.epa.gov/ncct/dsstox/index.html, accessed Dec 2008
4http://www.chemaxon.com, accessed Oct 2008
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All the descriptors and fingerprint information were encoded in Prolog so that they could be
used by the ILP system Aleph [19] as background knowledge. For the fingerprints we have
encoded the subset relation that enables to consider sets of fingerprint values. We take further
advantage of ILP facilities to accept domain specific knowledge useful to construct the mod-
els by encoding, in the background knowledge, a set of functional group definitions (methyl,
nh2amino, aldehyde, ketone, carboxylic acid, hydroxyl, cyano, and benzene).
5.3 Experimental Design
In the current study we have assessed two important topics in SAR problems for Drug Design:
the so called similarity bias; and the advantages of using relational learners. In this section
we first describe the experimental design concerning the similarity bias problem and then we
describe the experimental settings for the use of different relational learners and their combina-
tion.
5.3.1 Similarity Bias study
Toxicity results using the CPDBAS, NCTRER and DBPCAN data sets were published by
Pereira et al in [32]. In that study only propositional algorithms from Weka [33] were eval-
uated. We will take Pereira et al. results as a base line for the comparison of the ILP outcome.
In a first set of experiments we compare the performance of the ILP system with the Weka
results using the same set of molecules (no filtering was applied).
We then applied the filtering procedure as described in Section 4 to the set of all molecules
(toxic and non-toxic) with two threshold values for the Tanimoto Coefficient (0.6 and 0.8).
These two values produce a significant reduction in the number of similar molecules in the data
set(see Table 1) and therefore are able to attenuate the similarity bias.
In the last set of experiments, we have applied the filtering procedure separately to toxic and
non-toxic molecules and we have used the same two threshold values for the Tanimoto Coeffi-
cient.
Apart from the models’ accuracy, we have also assessed their complexity by computing the
average number of rules in the models and the average rule length.
5.3.2 Relational Learners study
In this study we have used the ILP system Aleph and the Graph Mining system Moss. To
assess the usefulness of these two relational learners we have used Aleph alone comparing
the accuracy results with the propositional learners of [32] and the comprehensibility of the
constructed models. We have used Moss to discover interesting graph fragments. We have also
used the fragments as new features (background knowledge) for Aleph.
All the experiments were carried out on a cluster of 8 nodes having two quad-core Xeon 2.4
GHz and 32 GB of RAM per node and running Linux Ubuntu 8.10. To estimate the predictive
quality of the classification models we performed 10 fold cross-validation experiments. The
ILP system used was Aleph 5.0 and the Graph Mining system was Moss.
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Table 2: Accuracy and standard deviation (in parenthesis). T.c. is the Tanimoto coefficient.
data set without mixed filtering separated filtering Weka
filtering T.c.= 0.8 T.c.= 0.6 T.c.= 0.8 T.c.= 0.6 best
(%) (%) (%) (%) (%) result
CPDBAS 67.3(4.2) 61.2(5.2) 63.1(6.8) 55.9(4.0) 60.5(2.9) 72.8
DBPCAN 90.5(7.0) 83.8(16.2) 84.8(5.2) 83.1(12.1) 78.8(21.3) 95.5
NCTRER 80.4(12.8) 83.5(7.0) 72.5(15.6) 78.6(4.4) 73.3(14.6) 87.1
6 Results and Discussion
Accuracy results for all the data sets used in the experiments are shown in Table 2. The results
by Pereira et al. ([32]), obtained using Weka, are included in the last column of the table for an
easy comparison.
As shown in Table 2, ILP has achieved slightly lower accuracy results than the best ones ob-
tained using Weka algorithms. The largest discrepancy is in the NCTRER data set where Weka
showed nearly 9% better accuracy. CPDBAS and NCTRER Weka best results were obtained
with Random Forest, an ensemble method that constructs models that although accurate are not
comprehensible. We should also note that we have no information concerning Weka’s individ-
ual Cross Validation (CV) runs and therefore we can not perform significance tests. Looking
at the individual CV runs Aleph performed better in one run with CPDBAS, in two runs with
DBPCAN and in four runs with NCTRER. We have also performed a set of trial experiments
where the limit of the search space was increased. This sequence of experiments show that as
the limit of the search space increases so increases the estimated accuracy of the models. The
results reported in Table 2 where obtained with the search limit imposed by the memory of our
machines, meaning that the reported results may be improved with more powerful computa-
tional resources.
A close inspection of Table 2 confirms the H0 hypothesis formulated in Section 1. Filtering
out the similar molecules from the original data sets significantly reduces the accuracy of the
constructed models. That means that using the original data sets without filtering may result in
over-optimistic results.
Table 3: Complexity of the constructed models. In each cell the left-hand-side numbers repre-
sent average number of rules (clauses) and its standard deviation (in parenthesis) and on the right
hand-side the average number of conditions (clause length) and its standard deviation (in paren-
thesis). T.c. is the Tanimoto coefficient.
data set without mixed filtering separated filtering
filtering T.c.= 0.8 T.c.= 0.6 T.c.= 0.8 T.c.= 0.6
CPDBAS 43.8(3.4)/3.2(0.2) 36.2(1.4)/3.4(0.2) 27.4(1.5)/3.3(0.3) 31.0(1.9)/3.3(0.2) 26.8(1.8)/3.0(0.1)
DBPCAN 1.7(0.7)/3.4(0.5) 2.0(0.0)/3.1(0.2) 2.0(0.5)/3.2(0.5) 2.2(0.4)/3.0(0.0) 1.9(0.3)/3.3(0.3)
NCTRER 5.4(0.7)/4.7(0.3) 2.3(0.5)/4.1(0.2) 1.8(0.8)/3.7(1.4) 2.9(0.3)/4.9(0.4) 2.0(0.7)/4.4(0.7)
Despite the slightly lower accuracy of the results, ILP was able to construct simple and com-
prehensible models. Table 3 shows the average number of rules of the models in each set of
experiments as well as the average model’s rule complexity (number of conditions). For ex-
ample, the DBPCAN models have a small number of rules with an average of 5 conditions per
rule.
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Figures 5 and 6 present some simple and informative rules. The upper rule of Figure 5 identifies
a toxic molecule if the molecule satisfies six conditions: the molecule must have a NH2 func-
tional group; its tautomer count must be larger or equal to 2; it must have two or less hydrogen
bond donors; it must have one of the three links between fingerprints: aa or da or dd5; the
molecule must have two fingerprint links with a path length shorter or equal to 4.
toxic(A) :-
nh2(A,B,C,D),
tautomer count(A,E), lteq(E,3),
doncount(A,F), lteq(F,2),
pharmacophore fingerprint(A,G,H,I),
pharmacophore group(G,[aa,da,dd]),
ltPharmacophoreArg2(H,4),
ltPharmacophoreArg3(I,10).
toxic(A) :-
bcut(A,B), lteq(B,5.667885),
ringcount(A,C), gteq(C,3),
mol polarizability(A,D), lteq(D,46.03),
fusedaromatic ringcount(A,E), gteq(E,2).
Figure 5: Two rules induced by Aleph for the CPDBAS data set. See text for an English translation
of the model.
toxic(A) :-
chemical fingerprint(A,B), fp group(B,[acetal,alkylbromide,alkylchloride]),
pharmacophore fingerprint(A,C,D,E), pharmacophore group(C,[aa,an,hh]),
ltPharmacophoreArg2(D,1), ltPharmacophoreArg3(E,10).
Figure 6: Single rule model constructed in one of the CV runs of the DBPCAN data set. This single
rule model has 100% accuracy on the test set of that CV run. See text for an English translation
of the model.
While the interpretation and translation of the generated rules into clear examples of high tox-
icity chemicals may be contentious at this stage, it is also tempting to mention a few examples
that seem to fit the models. One is the case of acrylamide, an important toxic compound that has
been associated with carcinogenesis and neurotoxicity. Acrylamide contains one NH2 amino
group, existing in three possible tautomeric forms; it holds no more than two hydrogen bond
donors (at one hydrogen bond donor site) and a da link that actually constitutes two links be-
tween the acceptor oxygen and the two donor hydrogens at the amino site (and whose path is
shorter than 4).
A preliminary dissection of the rules into its individual conditions can help shedding light on
their validity and, hence, predictive power. For example, while tautomerism alone cannot be
regarded as a potentially harmful or toxic feature, it can be expected that organic molecules
existing in a set of multiple inter-converting tautomeric forms are generally more prone to
cross-reactivity than molecules existing in a single form. Equally, while several biological
endogenous molecules contain a primary amine group, amines are also present in some families
of highly toxic agents such as the Anisidines and the Anilines, where some of their various
derivatives may comply with most or even all of the conditions in this rule. Thus, it is plausible
that the combination of the features described in the presented rules on a single molecule can
render it toxic and inappropriate for further drug design endeavors.
6.1 Graph Mining Results
The application of the frequent sub-graph discovery feature of Graph Mining (GM) resulted in
the identification of a small set of molecular scaffolds and/or fragments for each data set. The
most relevant fragments discovered by Moss, are listed in Table 4.
5aa means a link between two hydrogen bond acceptors; da means a link between an hydrogen bond acceptor
and an hydrogen bond donor; and dd represents a link between two hydrogen bond donors
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Figure 7: Chemical formula for nine entries detected on the CPDBAS data set through Graph
Mining.
Strikingly, the first entry found on the CPDBAS data set was the biphenyl scaffold (see Table 4).
Composed by two aromatic rings and 12 carbon atoms, this structure corresponds to a sizeable
sub-graph, which is present in some drugs, such as valsartan and telmisartan for the treatment
of hypertension. However, the biphenyl molecule itself is associated with decreased activity
of the hepatic cytochrome CYP1A2 enzyme, causing liver neoplasms and methemoglobinemia
[34]. Moreover, due to their symmetry, hydrophobicity, and ease of conjugation with halogen
atoms as in the pollutant polychlorinated biphenyls (PCBs) , several biphenyl derivatives have
been associated with bioaccumulation [35], neurotoxicity [36, 37], and endocrine disruption
[38]. A curious finding in this set is a fragment that is equivalent to propylhydrazine. This
sub-graph is present in a nitric oxide donor compound known as PAPA-NONOate, which has
been linked to testicular diseases, male infertility and chronic panchreatitis [39]. But the GM
algorithm also found a methylhydrazine fragment as a risk alert amongst the CPDBAS data set.
Methyhydrazines are associated with a number of diseases, particularly cancer [40, 41, 42].
The same applies to nitroso(propyl)amines and nitrosamines in general, which strongly interact
with the CYP2A6 cytochrome causing hepatitis B and C, liver cancer and cirrhosis, and several
other types of cancer [43, 44, 45]. Overall, five entries representing the nitrosamines have been
revealed through GM on the CPDBAS data set (Table 4 and Figure 7).
The GM results obtained for the DBPCAN data set clearly bring focus to the halogens and the
haloalkanes. We could certainly analyze these results one-by-one. Indeed, most of the entries
in Table 4 correlate with some form of toxic effect. For example, bromomethane was used as a
pesticide before being correlated with diseases of agricultural workers and heart diseases [46].
However, considering the small size of the found sub-graphs it seems even more obvious to
us that the results should be assessed globally and by trying to integrate them as fragments or
functions (chemophores) of organic molecules. With this in mind, we carried out substructure
searches for each found sub-graph on two small databases of drugs withdrawn from the market
and illicit molecules [47, 48, 49]. The sub-graph corresponding to bromomethane was found in
three withdrawn drugs and in five illicit molecules. Remoxipride, for example, was a drug used
in the treatment of schizophrenia that was withdrawn from the market due to toxicity concerns
(incidence of aplastic anemia) [50]. Even though the detection of the bromomethane sub-graph
may translate into a solitary bromine substituent in a molecule, and despite the fact that a few
drug molecules in the market include bromine as a substituent, the presence of this particular
halogen is highly discouraged by reputable medicinal chemists [51].
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Table 4: Some molecular fragments discovered by Moss in SMILES [14] format.
CPDBAS DBPCAN NCTRER
c1(:c:c:c:c:c:1):c1:c:c:c:c:c:1 Cl-C(-Cl)-C-C Br O-c1:c:c:c(-C(-C)-C):c:c:1
N(-N)-C-C-C Br-C Br-C-C O-c:c:c:c-C(-C)-C
N(-N)(-C)-C-C Cl-C(-Cl)-C Cl O-c(:c):c:c:c-C(-C)-C
N(-N)(-C)-C-C-C Cl-C-C-C Cl-C O-c:c:c:c(-C(-C)-C):c
N(-N=O)-C-C Cl-C=C-C Cl-C=C O-c(:c:c):c:c:c-C(-C)-C
N(-N=O)(-C)-C Cl-C-Cl O=C-C-Cl O-c(:c):c:c:c(-C(-C)-C):c
N(-N=O)-C-C-C Cl-C-C Cl-C-C-Cl O-c:c:c:c(-C(-C)-C):c:c
N(-N=O)(-C)-C-C O=C(-C)-C-Cl
N(-N=O)(-C)-C-C-C
The GM results obtained for the NCTRER data set seem to highlight a group of acyclic al-
cohols, with the exception of 4-(propan-2-yl)phenol. Substructure searches conducted on the
same databases did not retrieve any results for these fragments. However, the matched sub-
graphs are found in molecules of the NCTRER set that hold well-known hormonal effects,
particularly due to their affinity for the estrogen receptor. 17beta estradiol is a emblematic ex-
ample, herein matched by the 4-(propan-2-yl)phenol sub-graph. Other examples include several
bisphenols and diethylstilbestrol analogues. Indeed, it would be interesting to analyse putative
correlations between these particular sub-graphs and the hormonal and carcinogenic potential
of the molecules onto which they match.
7 Conclusions
In the present paper we presented iLogCHEM, an interactive tool that helps experts easily inter-
act with relational learners in the drug design process. In an iterative process a researcher may
get help in the search for new drugs by visually inspecting the models constructed by the ma-
chine learning algorithms and providing constraints to improve the model for the next iteration.
No details of the algorithm’s workings are presented to the expert. The researcher only sees
graphical representations of the molecules and patterns and SMILES notation descriptions.
We have also reported in this paper a study to assess the effect of having a high degree of
similarity amongst molecules in drug collections on the outcome of predictive models for drug
toxicity. This “similarity bias” observed in most drug data bases makes the predictive results
too optimistic. Our results show that filtering out similar molecules with a Tanimoto coefficient
of 0.8 substantially reduces the data sets (demonstrating the high degree of compound similarity
in the data bases) and drastically reduces the predictive power of the classifiers. This reduction
in predictive accuracy is statistically significant in almost all of our experiments.
The accuracy of the models produced with ILP is not significantly worse than the accuracy
values of the propositional learners. However, the constructed ILP models are simple, under-
standable, and incorporate the functional group definitions supplied by an expert.
One last study reported in this paper concerns the use of a Graph Mining algorithm to find
molecular fragments implicated in toxic effects, which might help stream-lining the drug de-
sign process. We have integrated these molecular fragments descriptions into the background
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knowledge of an ILP system that was able to use them to induce very simple and informative
rules on the toxicity of different chemical compounds.
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